Fresenius SE & Co. KGaA

FRE

DE0005785604

Healthcare Facilities & Services

Market Closed - Xetra Other stock markets 09:05:07 23/05/2024 pm IST			After market 11:31:17 pm
28.36 ^EUR	+2.64%		28.27	-0.32%

06:19am	Ailing hospitals slow down German medical technology sector	DP
20/05	JPMorgan raises target for Fresenius SE to 37.60 euros - 'Neutral'	DP

FRESENIUS SE : Barclays gives a Buy rating

May 13, 2024 at 03:57 pm IST

Barclays analyst Hassan Al-Wakeel maintains his Buy rating on the stock. The target price is slightly modified from 35 to 36 EUR.

Latest news about Fresenius SE & Co. KGaA

Ailing hospitals slow down German medical technology sector	09:49am	DP
JPMorgan raises target for Fresenius SE to 37.60 euros - 'Neutral'	20/05	DP
FRESENIUS SE : JP Morgan remains Neutral	20/05	ZD
What does the new atlas mean for the 'hospital jungle'?	17/05	DP
Moody’s Revises Outlook on Fresenius Medical Care to Stable from Negative	17/05	MT
Launch of new quality atlas for hospitals	17/05	DP
Moody’s Affirms Fresenius' Rating, Outlook on Improving Profitability	16/05	MT
Union demands Lauterbach approach the federal states on hospital reform	16/05	DP
Dobrindt demands approach to federal states on hospital reform	16/05	DP
Lauterbach's 'revolution' for clinics on the way	15/05	DP
Cabinet launches hospital reform	15/05	DP
Cabinet to get hospital reform underway	15/05	DP
FRESENIUS SE : Receives a Buy rating from DZ Bank	14/05	ZD
FRESENIUS SE : Jefferies reiterates its Buy rating	14/05	ZD
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank...	13/05
FRESENIUS SE : Barclays gives a Buy rating	13/05	ZD
FRESENIUS SE : Berenberg gives a Buy rating	13/05	ZD
Fresenius Medical sees up to 2% US dialysis growth by year-end	11/05	RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	10/05	MT
FRESENIUS : Preparing for a strong(er) future performance	10/05
FRESENIUS SE : Deutsche Bank keeps its Buy rating	09/05	ZD
Health Care Slips as Defensive Investors Rotate to Utilities - Health Care Roundup	09/05	DJ
Home REIT cuts borrowings, Genflow shares restored	09/05	AN
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	08/05	MT
Fresenius becomes more optimistic thanks to subsidiary Kabi - exit from Vamed	08/05	DP

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).

Sector

Healthcare Facilities & Services

Calendar

31/07/2024 - Q2 2024 Earnings Call

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

FRESENIUS : Preparing for a strong(er) future performance

May 10, 2024 at 01:16 pm IST

More Strategies

Ratings for Fresenius SE & Co. KGaA

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

27.63 EUR

Average target price

36.72 EUR

Spread / Average Target

+32.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
FRESENIUS SE & CO. KGAA	+1.03%	16.86B
HCA HEALTHCARE, INC.	+15.85%	83.4B
CVS HEALTH CORPORATION	-27.55%	72.11B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	27.04B
LABCORP HOLDINGS INC.	-12.73%	16.96B
QUEST DIAGNOSTICS INCORPORATED	+2.63%	15.76B
NATERA, INC.	+71.41%	13.33B
REDE D'OR SÃO LUIZ S.A.	+1.74%	12.76B
TENET HEALTHCARE CORPORATION	+70.91%	12.74B
FRESENIUS MEDICAL CARE AG	+1.11%	12.32B

Other Healthcare Facilities & Services

Fresenius SE & Co. KGaA

Equities

FRE

DE0005785604

Healthcare Facilities & Services

FRESENIUS SE : Barclays gives a Buy rating

Latest news about Fresenius SE & Co. KGaA

Chart Fresenius SE & Co. KGaA

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Fresenius SE & Co. KGaA

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Healthcare Facilities & Services